Researchers discover possible new biomarker of MS-like autoi

It has been known for several years that the diagnosis "multiple sclerosis" conceals a whole range of different illnesses, each requiring customized treatment. Researchers at the University of Basel and the University Hospital of Basel have now described a possible new MS-like disease and explained how to diagnose it.

Related Keywords

Switzerland , Berlin , Germany , Brazil , Swiss , German , Fondation Pierre Mercier , Megan Craig , Laila Kulsvehagen , Department Of Neurology , European Committee For Treatment , University Hospital Of Basel , Goldschmidt Jacobson Foundation , University Hospital Basel , University Hospital , Heinrich Heine University , Research In Multiple Sclerosis Clinical Fellowship , National Multiple Sclerosis Society , Research Center , Swiss National Science Foundation , University Hospital Of Basel Propatient Foundation , Ruhr University Bochum , Clinical Research Of The University Basel , University Of Basel , Clinical Research , Clinical Neuroimmunology , Propatient Foundation , Swiss National Science , European Committee , Multiple Sclerosis Clinical Fellowship , Swiss Government Excellence Scholarship , Ana Beatriz , Trygve Tellefsens Legat Scholarship , Autoimmune Disease , Biomarker , Antibodies , Ntibody , Central Nervous System , Lycoprotein , Hospital , Immune System , Mmunoglobulin , Inflammation , Multiple Sclerosis , Myelin , Nerve , Nervous System , Eurology , Paralysis , Research , Clerosis ,